Latest issue of Lyme Times looks at gender bias in Lyme disease

|

March 12, 2019

The Lyme Times, Winter 2019

The Winter 2019 issue of the Lyme Times offers a look at Doing Harm: The Truth About How Bad Medicine and Lazy Science Leave Women Dismissed, Misdiagnosed, and Sick, by Maya Dusenbury.

Throughout the book, Dussenbury discusses medical gender bias in the context of such topics as heart disease, autoimmune illnesses, and chronic pain. But the chapter that will likely resonate most with the Lyme community is one entitled “Contested Illnesses: When Diseases Are ‘Fashionable.’”

Dusenbury devotes a lot of attention to Lyme disease in this chapter, along with other conditions that come with “medically unexplained symptoms,” such as chronic fatigue syndrome and multiple chemical sensitivities. Read an excerpt in this issue.

Other topics we cover:

  • Which Lyme disease treatments are most effective?
  • Let’s abandon the “Post-treatment Lyme disease” label
  • What is plasmapheresis?
  • Canadian Lyme patients charge government with “toxic tokenism”

and much more.

Membership gives you free online access

Complete online access to the current issue of the Lyme Times as well as previous issues is available to members of Lymedisease,org. (Non-members can view excerpts from the Winter 2019 issue.)

Help us advocate for change, raise awareness, and fund research that can improve the lives of people living with Lyme disease. Become a member today and start reading this issue immediately.

Dorothy Leland
Written by

Dorothy Leland

Dorothy Leland is a longtime advocate and researcher focused on Lyme disease education, policy awareness, and patient support. She has contributed to numerous publications and works closely with medical professionals and organizations to improve understanding and treatment of tick-borne diseases.

Do You Have Lyme Disease?

Use our symptom checklist to better understand possible Lyme disease signs and next steps.

Newsletter Sign-up

Support LymeDisease.org

Your support helps us advocate for patients and fund critical Lyme disease research.

Related Articles